Suntrust Banks’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
MG
WBG
PVH
HF
Suntrust Banks's XPH Position: Q3 2015 in Review
Suntrust Banks sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2015, closing a stake of 14,020 shares — an estimated $873K sold.
Suntrust Banks first reported a position in XPH in Q4 2013 and held it in 7 quarters. The position peaked at $873K in Q2 2015. 77 funds tracked by Wall St. Rank hold XPH as of Q3 2015.
- Suntrust Banks reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
- Suntrust Banks sold 14,020 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2015, an estimated $873K.
- Suntrust Banks first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2013 and held it in 7 quarters.
- Suntrust Banks's State Street SPDR S&P Pharmaceuticals ETF position peaked at $873K in Q2 2015.
- 77 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2015.
Based on Suntrust Banks's 13F filing for Q3 2015, filed 16 Nov 2015.